IMUX Live signaler | Maksimer profitt med Getagraph.com

KJøP 115213 min ago

@ $1.320

Utstedt: 14 feb 2024 @ 21:57

Avkastning: 3.79%

Forrige signal: feb 9 - 15:39

Forrige signal: Selg

Avkastning: 4.35 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases...

Stats
Dagens volum	112 207
Gjennomsnittsvolum	511 911
Markedsverdi	123.20M
EPS	$0 ( 2024-02-22 )
Neste inntjeningsdato	( $-0.270 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.650
ATR14	$0.00700 (0.51%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-04	Howson Tamar D	Buy	64 959	Stock Option
2024-03-04	Howson Tamar D	Sell	10 000	Stock Option
2024-03-04	Howson Tamar D	Sell	10 000	Stock Option
2024-03-04	Howson Tamar D	Sell	9 986	Stock Option
2024-03-04	Howson Tamar D	Sell	15 000	Stock Option

INSIDER POWER
44.48
Last 97 transactions
Buy: 5 390 136 \| Sell: 1 509 904

Volum Korrelasjon

Lang: 0.18 (neutral)

Kort: 0.00 (neutral)

Signal:(49.556) Neutral

Immunic Inc Korrelasjon

10 Mest positive korrelasjoner
TOP	0.913
HOWL	0.902
BNIXU	0.887
GAINL	0.884
OLMA	0.874
IPKW	0.873
EOLS	0.87
ALGS	0.867
LILAK	0.867
ISNS	0.866

10 Mest negative korrelasjoner
MMAC	-0.89
BOCH	-0.886
SHSP	-0.857
PEP	-0.832
NETE	-0.826
AMRB	-0.825

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Immunic Inc Korrelasjon - Valuta/Råvare

-0.82
( strong negative )

-0.36
( neutral )

0.00
( neutral )

-0.37
( neutral )

0.00
( neutral )

0.73
( moderate )

Immunic Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-111 000 (0.00 %)
EPS:	$-2.11

FY	2023
Omsetning:	$0
Bruttogevinst:	$-111 000 (0.00 %)
EPS:	$-2.11

FY	2022
Omsetning:	$0
Bruttogevinst:	$-77 000.00 (0.00 %)
EPS:	$-4.85

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.93

Financial Reports:

No articles found.

Immunic Inc

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

Sanntidsoppdatering for Immunic Inc [IMUX]

Upcoming Earnings Alert